Our data begins to fill this gap, showing that CD5 is indeed highly expressed in malignant CTCL CD4 T cells, particularly in patch/plaque lesions, but that expression is heterogeneous and can be lost in more robust MF tumors. This evidence concerns the gene CD5 and mycosis fungoides.